Atreca
Latest round
- Series C
Last raised
- Sep 2018
Total raised
- $208M
Investors
- 11
About Atreca
Atreca, Inc. is a biotechnology company specializing in the discovery of therapeutics and diagnostics through innovative antibody technology.Founded in 2011, Atreca, Inc. operates out of Redwood City, US. The company utilizes a unique approach to identify and develop antibodies targeting specific diseases. The founders, Jonathan Woo and Tito Serafini, have backgrounds in biotechnology and pharmaceuticals.35 million shares at USD 17 each.Atreca, Inc. offers a range of innovative biopharmaceutical products focusing on the development of immune-based therapeutics. Their core services include proprietary antibody discovery platforms designed to identify effective treatments for cancer and autoimmune diseases.In 2022, Atreca, Inc.Atreca, Inc. plans to expand its product line with new antibody therapeutics currently under development, with anticipated launches in the next few years. The company aims to broaden its market presence in Europe and Asia by 2025.95 mn will be utilized to accelerate the development of their pipeline products and enhance research capabilities.
Who invested in Atreca
11 investors across 3 rounds
See all investors in Atreca
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atreca
Who invested in Atreca?
Atreca has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atreca raised?
Atreca has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Atreca last raise money?
Atreca's most recent round on record is a Series C, in Sep 2018.
What does Atreca do?
Atreca is a biotechnology company.
Where is Atreca headquartered?
Atreca is headquartered in Redwood City, US.
Which VCs invest in companies like Atreca?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Atreca's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Atreca? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.